Thomas R Caferro

Title: Thomas R Caferro: Innovator in Androgen Receptor Modulation

Introduction

Thomas R Caferro is a notable inventor based in Holly Springs, NC (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that modulate androgen receptors. With a total of 2 patents to his name, Caferro's work is recognized for its potential impact on therapeutic applications.

Latest Patents

Caferro's latest patents include innovative compounds and methods related to tricyclic quinolinone and tricyclic quinoline. The first patent describes novel non-steroidal tricyclic quinolinone and tricyclic quinoline compounds that act as agonists, partial agonists, and antagonists for androgen receptors (AR). This patent outlines their preparation and various uses. The second patent focuses on compounds, pharmaceutical compositions, and methods for modulating processes mediated by steroid receptors. It emphasizes the preparation and use of non-steroidal compounds that interact with the androgen receptor, including methods for synthesizing critical intermediates.

Career Highlights

Thomas R Caferro is currently employed at Ligand Pharmaceuticals, Inc., where he continues to advance his research in the field of androgen receptor modulation. His work is characterized by a commitment to developing innovative solutions that address unmet medical needs.

Collaborations

Throughout his career, Caferro has collaborated with esteemed colleagues, including Robert Higuchi and Lin Zhi. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic compounds.

Conclusion

Thomas R Caferro's contributions to the field of pharmaceutical sciences, particularly in androgen receptor modulation, highlight his innovative spirit and dedication to advancing medical research. His patents reflect a commitment to developing effective therapeutic solutions.